Related Experiment Video

Updated: Mar 11, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.1K

Antithrombotic Therapy to Reduce Ischemic Events in Acute Coronary Syndromes Patients Undergoing Percutaneous

Freek W A Verheugt1

  • 1Division of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG), Oosterpark 9, Amsterdam 1091 AC, Netherlands.

Interventional Cardiology Clinics
|November 26, 2016
PubMed

Insights

Antithrombotic therapy prevents complications after percutaneous coronary intervention (PCI). For acute coronary syndromes (ACS), dual antiplatelet therapy and anticoagulants are crucial, with P2Y12 blockers continued for 12 months.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Antithrombotic therapy is vital for preventing periprocedural death and myocardial infarction following percutaneous coronary intervention (PCI).
  • Platelets and the coagulation cascade are key players in acute coronary syndromes (ACS) pathogenesis.
  • Therapeutic strategies must address both pathways for optimal outcomes in ACS patients undergoing PCI.

Purpose of the Study:

  • To highlight the critical role of antithrombotic therapy in periprocedural management of patients undergoing PCI.
  • To emphasize the increased importance of antithrombotic therapy in ACS compared to elective PCI.
  • To outline current antithrombotic agents and their recommended durations of use.

Main Methods:

  • Review of established antithrombotic agents including aspirin, P2Y12 inhibitors, glycoprotein IIb/IIIa inhibitors, and parenteral anticoagulants.
  • Discussion of treatment duration and specific agent recommendations based on patient risk and clinical presentation.
  • Focus on high-risk patients, particularly those with ST-elevation acute coronary syndrome undergoing primary angioplasty.

Main Results:

  • Aspirin, P2Y12 blockers, glycoprotein IIb/IIIa blockers, and parenteral anticoagulants are primary agents used.
  • P2Y12 blockers require continuation for at least 12 months post-procedure.
  • Glycoprotein IIb/IIIa receptor antagonists are recommended for high-risk patients, especially in primary angioplasty for STEMI.

Conclusions:

  • Comprehensive antithrombotic therapy is essential for reducing periprocedural complications in PCI.
  • Tailored antithrombotic strategies, including prolonged P2Y12 inhibition and use of glycoprotein IIb/IIIa inhibitors in high-risk cases, improve patient outcomes in ACS.
  • Effective management of thrombotic pathways is paramount in interventional cardiology settings.

Keywords:
Acute coronary syndromesOral anticoagulationOral antiplatelet therapyParenteral anticoagulationParenteral antiplatelet therapyPercutaneous coronary intervention

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.7K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
372
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
445